Results 121 to 130 of about 176,455 (318)

Mixing It Up With MT2: Unbiased Mass Measurements at Hadron Colliders

open access: yes, 2011
Recently, much progress has been made on techniques to measure the masses of new particles with partially-invisible decays at a hadron collider. We examine for the first time the realistic application of MT2-based measurement methods to a fully hadronic ...
Curtin, David
core   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Detecting kinematic boundary surfaces in phase space: particle mass measurements in SUSY-like events

open access: yesJournal of High Energy Physics, 2017
We critically examine the classic endpoint method for particle mass determination, focusing on difficult corners of parameter space, where some of the measurements are not independent, while others are adversely affected by the experimental resolution ...
Dipsikha Debnath   +5 more
doaj   +1 more source

Direct Neutrino Mass Experiments

open access: yes, 2016
With a mass at least six orders of magnitudes smaller than the mass of an electron -- but non-zero -- neutrinos are a clear misfit in the Standard Model of Particle Physics.
Mertens, Susanne
core   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Discriminating Electroweak-ino Parameter Ordering at the LHC and Its Impact on LFV Studies

open access: yes, 2009
Current limit on the dark matter relic abundance may suggest that $|\mu|$ should be smaller than prediction in the minimal supergravity scenario (mSUGRA) for moderate $m_0$ and $m_{1/2}$. The electroweak-ino parameter $M_1, M_2$ and $|\mu|$ are then much
A. Barr   +26 more
core   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy